Figure 1.
Patients with OHI+ lymphoma have decreased 3-year OS and EFS. Kaplan-Meier curves comparing the 3-year OS (A) and EFS (B) between OHI− (70 patients) and OHI+ patients (65 patients). Statistical significance was determined using the log-rank (Mantel-Cox) test (∗∗∗∗P < .0001). An event was defined as death, refractoriness, progression, or relapse of lymphoma. (C) Predicted survival of OHI− and OHI+ patients based on the lymphoma-relevant prognostic indexes (left) and the observed survival (right). Statistics were calculated using the χ2 test. ∗∗∗∗P < .0001. (D) Forest plot of the OR and 95% CI of the predicted OHI+/− and the observed survival of patients with OHI+/− lymphoma. The number of patients at risk at each time point is shown beneath the survival curves. ns, nonsignificant.

Patients with OHI+ lymphoma have decreased 3-year OS and EFS. Kaplan-Meier curves comparing the 3-year OS (A) and EFS (B) between OHI− (70 patients) and OHI+ patients (65 patients). Statistical significance was determined using the log-rank (Mantel-Cox) test (∗∗∗∗P < .0001). An event was defined as death, refractoriness, progression, or relapse of lymphoma. (C) Predicted survival of OHI− and OHI+ patients based on the lymphoma-relevant prognostic indexes (left) and the observed survival (right). Statistics were calculated using the χ2 test. ∗∗∗∗P < .0001. (D) Forest plot of the OR and 95% CI of the predicted OHI+/− and the observed survival of patients with OHI+/− lymphoma. The number of patients at risk at each time point is shown beneath the survival curves. ns, nonsignificant.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal